Abstract: A clear top coat composition for application over a wet nail polish, comprising cellulose acetate propionate ester, a mixture of solvents free of toluene, and a plasticizer, providing a dry non-tacky, non-brittle solid coat which is quick drying when applied over a nail polish while wet.
Abstract: A mascara composition which comprises a mixture of:(a) pseudo-latex particles, having an average diameter ranging from 10 to 300 nm, of a water-insoluble filmogen polymer derived form cellulose selected from the group consisting of cellulose ethers, non-ionic cellulose esters and anionic cellulose esters having carboxylic acid functions, the said carboxylic acid functions being neutralized to a neutralization amount between 10 and 80 percent by means of a nonvolatile basic agent, and(b) at least one wax having a melting point between 60.degree. C. and 110.degree. C.
Type:
Grant
Filed:
January 17, 1995
Date of Patent:
May 5, 1998
Assignee:
L'Oreal
Inventors:
Nathalie Mougin, Jean Mondet, Bertrand Piot, Alex Junino, Jeanne Patraud
Abstract: A cosmetic composition for forming a peelable skin mask is provided based on a combination of polyvinyl alcohol and a hydrophobically-modified acrylate or methacrylate polymer. Most effective is a combination of two weight grades of polyvinyl alcohol, a low weight grade having a number average molecular weight ranging from about 15,000 to about 27,000 and a high weight grade having a number average molecular weight ranging from about 44,000 to about 65,000. The hydrophobically-modified acrylate or methacrylate polymer preferably is a copolymer formed from a carboxylic monomer and a C.sub.8 -C.sub.30 acrylate ester.
Type:
Grant
Filed:
July 30, 1993
Date of Patent:
May 5, 1998
Assignee:
Chesebrough-Pond's USA Co., Division of Conopco, Inc.
Abstract: Cosmetic composition containing at least one nonionic surface-active agent of the alkyl polyglycoside and/or polyglycerolated type and at least one crosslinked copolymer of maleic anhydride/(C.sub.1 -C.sub.5)alkyl vinyl ether.The invention relates to a cosmetic composition containing, in a cosmetically acceptable medium, at least one nonionic surface-active agent from the alkyl polyglycoside class and/or one polyglycerolated nonionic surface-active agent and at least one crosslinked copolymer of maleic anhydride/(C.sub.1 -C.sub.5)alkyl vinyl ether, as well as to a cosmetic treatment process consisting in applying to keratinous matter a cosmetically effective quantity of this composition.
Abstract: A method and composition is provided for treating skin conditions including those arising from dermatologic disorders, chronoaging and environmental abuse. Non-ring esterified C.sub.11 -C.sub.30 alkyl or alkenyl esters of salicylic acid are used as the active component in combination with a pharmaceutically acceptable carrier. Most preferred is tridecyl salicylate.
Type:
Grant
Filed:
June 25, 1996
Date of Patent:
April 21, 1998
Assignee:
Elizabeth Arden Company
Inventors:
Angel Augusto Guerrero, Peter Ladislaus Dorogi, Thomas Charles Klepacky
Abstract: The present invention relates to gelled emulsion particles obtained when predetermined volumes, especially drops, of an emulsion with an aqueous external phase, containing an appropriate reagent in solution in the said aqueous phase, are added to a gelling solution and left therein for a period of time which depends on the degree of gelling desired for the said particles.It further relates to compositions--especially solutions, gels or emulsions with an aqueous external phase--in which the said particles are present.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
April 14, 1998
Assignee:
Helene Rubenstein, Inc.
Inventors:
Anne Clement, Pierre Fodor, Gerard Guth, Nathalie Thiollet
Abstract: Fatty hydroxyethyl imidazolines inhibit esterification of retinol into inactive retinyl esters. Thus, effects of the retinol or retinyl esters in combination with fatty hydroxyethyl imidazolines are analogous to treatment with retinoic acid.
Type:
Grant
Filed:
September 27, 1996
Date of Patent:
April 14, 1998
Assignee:
Cheseborough-Pond's USA Co., Division of Conopco, Inc.
Abstract: A scalp and hair treatment method and composition wherein the composition comprises deionized water, a vasodilator (such as ethyl nicotinate and/or capsicum extract), a magnesium salt, and a hydrolyzed protein. The composition can be applied on a monthly or bi-monthly basis to the scalp and hair for about 30 minutes and rinsed away with water.
Abstract: A composition and method for treatment of skin. The composition comprises a pharmaceutically acceptable carrier containing a bilayer component having one or more polar terminus groups and one or more non-polar terminus groups separated from said polar terminus groups capable of penetrating the outer surface of the skin to form an aligned bilayer within the stratum corneum. The bilayer assists in the formation of bilayer lamellae that is believed to replicate the bilayer lamellae present in healthy skin. The composition is topically applied to the skin as often as is required.
Type:
Grant
Filed:
November 3, 1995
Date of Patent:
April 14, 1998
Assignee:
Ocular Research of Boston, Inc.
Inventors:
Donald R. Korb, Thomas Glonek, Jack V. Greiner
Abstract: A far-infrared radiating cream for curing muscle ache and stiffness, composed of 4 wt % of a far-infrared radiating compound which is composed of 70 wt %-90 wt % of powdered perlite, 7 wt %-20 wt % of Ta.sub.2 O.sub.5, 3 wt %-10 wt % Nb.sub.2 O.sub.5, and 96 wt % of a cream which is composed of propylene, cetanol, squalane, paraffin oil, stearyl alcohol, glycine, propyl paraben, dL-.alpha.-tocopherol. The cream is capable of radiating far-infrared in the wavelength range of 3-16 .mu.m when stimulated by body heat.
Abstract: Disclosed is a glycol-containing base gel composition having reduced skin irritation potential, in which a cosmetically active agent (e.g., deodorant active agent, sunscreen, antiperspirant active agent, etc.) can be incorporated to provide a cosmetic gel (e.g., soft gel or stick) composition. The gelling agent for the gel composition can be a soap. The base gel composition includes at least one glycol having a structure of the formula H(OC.sub.3 H.sub.6).sub.n OH, where n represents the number of repeating propylene oxide groups and ranges from 1-80, with the provisos that: (1) more than zero, and up to 100% by weight, of the glycol component, has n=3 or 4; (2) less than 20% by weight of the glycol component has n=1; (3) not more than 90% by weight of the glycol component has n=2; and (4) not more than 90% by weight of the glycol component has n greater than or equal to 5.
Type:
Grant
Filed:
August 14, 1996
Date of Patent:
March 24, 1998
Assignee:
Colgate-Palmolive Company
Inventors:
Peter R. Hilliard, Jr., Bhalchandra D. Moghe, Lloyd Ross
Abstract: An agent for treating a skin disease selected from the group consisting of a contact dermatitis treating agent, a xerosis senilis treating agent, an asteatosis treating agent, a housewives eczema treating agent, a keratosis treating agent, an eczema chronicum treating agent, a miliaria treating agent and a diaper rash treating agent, which contains hyaluronic acid and/or its salt having an average molecular weight of from 800,000 to 4,000,000, as an active ingredient.
Abstract: An anhydrous cosmetic stick composition with improved transfer resistance comprising, by weight of the total composition:a) 10-70% of a volatile solventb) 0.1-40% of a polymeric organosiloxane emulsifier containing at least one hydrophilic radical and at least one lipophilic radical.
Type:
Grant
Filed:
November 3, 1995
Date of Patent:
March 10, 1998
Assignee:
Revlon Consumer Products Corporation
Inventors:
Ann Marshall Krog, Salvatore Joseph Barone, Natividad R. Jose, Gina Alyse McLaughlin
Abstract: A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a pharmaceutically acceptable alcohol. The composition can optionally comprise a pharmaceutically acceptable acid or a combination of pharmaceutically acceptable acids. The solution can optionally be encapsulated in hard gelatin capsules or soft elastic gelatin capsules. The solution can optionally be granulated with a pharmaceutically acceptable granulating agent.
Type:
Grant
Filed:
May 4, 1995
Date of Patent:
March 10, 1998
Assignee:
Abbott Laboratories
Inventors:
Laman A. Al-Razzak, Kennan C. Marsh, Dilip Kaul, Lourdes P. Manning
Abstract: A guanidine derivative represented by formula (1), (2), (3) or its acid addition salt and a production process thereof ##STR1## wherein each of A and B is a C.sub.2 -C.sub.8 alkylene, D is a single bond, --CO-- or a C.sub.1 -C.sub.5 alkylene, E is H, a lower alkyl or the like, m is 1 to 6, n is 0 to 6 and R.sup.1 is H, a lower alkyl or the like, l is 1 to 10 and G is H, --OH or the like and a skin cosmetic containing the same. It can exert excellent keratin layer softening effect continuously for a long period of time.
Abstract: The present invention is to provide an adhesive type cosmetic product prepared by coating 5-50 parts by weight of the composition comprising 5-40% by weight of vitamin E, 5-50% by weight of vitamin A and 15-60% by weight of concentrated natural aloe extract, and 50-95 parts by weight of an adhesive in a mixture or in a laminate structure on a carrier film; and process for preparing thereof.The adhesive type cosmetic product according to the present invention shows excellent effect for preventing, removing or alleviating wrinkles or furrows as compared to the conventional cosmetic compositions for removing wrinkles. In addition, the effect exhibited can be maintained for a long time and reappearance of furrows or wrinkles can be avoided, whereby providing very useful cosmetic product for removing wrinkles or furrows.
Abstract: A novel microparticle preparation comprising microparticles of a polymer which contain a drug and are at least partially or wholly coated with a water-soluble inorganic salt, a water-soluble organic acid or a water-soluble salt of an organic acid, which acts as an agent for preventing aggregation of the microparticle preparation is disclosed. The preparation is produced by spraying a polymer solution containing a drug and a solution or dispersion of a water-soluble inorganic salt, a water-soluble organic acid or a water-soluble salt of an organic acid from different nozzles and contacting them with each other in a spray dryer. In this procedure, if desired, a non-ionic surfactant may be added to the solution of the water-soluble inorganic salt, the water-soluble organic acid or the water-soluble salt of organic acid, or a solution of non-ionic surfactant may be sprayed from the other nozzle simultaneously.
Abstract: Salicylic acid derivatives act as inhibitors of tyrosinase and are used in compositions for the purpose of lightening the skin or of treating pigmental blemishes.